Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats
- PMID: 15682308
- DOI: 10.1007/s00213-004-2067-4
Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats
Abstract
Rationale: Antagonists acting at the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors inhibit various phenomena associated with exposures to nicotine (e.g., tolerance, sensitization, dependence, and intravenous self-administration). These effects are often discussed in terms of nicotine-induced glutamate release with subsequent glutamate-dependent stimulation of dopamine metabolism and neuronal plasticity in brain areas critically involved in drug-addiction mechanisms. However, it is also well established that certain types of NMDA receptor antagonists (channel blockers) potently bind to nicotinic receptors and may act as nicotinic receptor antagonists.
Objective: The present study aimed to evaluate the discriminative-stimulus effects of the NMDA receptor channel blockers (+)MK-801, dextromethorphan, and memantine in rats trained to discriminate nicotine from its vehicle.
Methods: Adult male Wistar rats were trained to discriminate 0.6 mg/kg nicotine from saline under a two-lever, fixed-ratio 10 schedule of food reinforcement. During test sessions, injections of (+)MK-801 (0.03--0.3 mg/kg, i.p.), dextromethorphan (30 mg/kg, s.c.), or memantine (1--10 mg/kg, i.p.) were co-administered with s.c. nicotine (0.075--0.6 mg/kg; interaction tests) or saline (generalization tests). Additional interaction and generalization tests were conducted with the selective nicotinic receptor antagonists mecamylamine (0.1--3 mg/kg, s.c.) and MRZ 2/621 (0.3--10 mg/kg, i.p.), and the mGlu5 receptor antagonist MPEP (3--10 mg/kg, i.p.).
Results: In generalization tests, none of the compounds produced any appreciable levels of substitution for nicotine. The nicotine discriminative-stimulus control was dose dependently attenuated by mecamylamine (ED(50)=0.67 mg/kg) and MRZ 2/621 (ED(50)=9.7 mg/kg). Both agents produced a marked downward shift in the nicotine dose-response curve. Memantine and MPEP slightly attenuated nicotine discriminative-stimulus effects, while (+)MK-801 and dextromethorphan did not affect the nicotine-appropriate responding.
Conclusions: NMDA receptor channel blockers, such as (+)MK-801, dextromethorphan, and memantine, have minimal interactions with the discriminative-stimulus effects of nicotine.
Similar articles
-
Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats.Pharmacol Biochem Behav. 1996 Sep;55(1):163-8. doi: 10.1016/0091-3057(95)02290-2. Pharmacol Biochem Behav. 1996. PMID: 8870053
-
Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.Neuropharmacology. 1996;35(12):1709-19. doi: 10.1016/s0028-3908(96)00147-5. Neuropharmacology. 1996. PMID: 9076750
-
Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists.Pharmacol Biochem Behav. 1998 Jan;59(1):159-69. doi: 10.1016/s0091-3057(97)00379-1. Pharmacol Biochem Behav. 1998. PMID: 9443551
-
Discriminative stimulus effects of ethanol: neuropharmacological characterization.Alcohol. 1999 Jan;17(1):63-80. doi: 10.1016/s0741-8329(98)00035-4. Alcohol. 1999. PMID: 9895039 Review.
-
Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation.Amino Acids. 2000;19(1):157-66. doi: 10.1007/s007260070044. Amino Acids. 2000. PMID: 11026484 Review.
Cited by
-
Nicotine drug discrimination and nicotinic acetylcholine receptors in differentially reared rats.Psychopharmacology (Berl). 2018 May;235(5):1415-1426. doi: 10.1007/s00213-018-4850-7. Epub 2018 Feb 21. Psychopharmacology (Berl). 2018. PMID: 29464302
-
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.J Pharmacol Exp Ther. 2008 Aug;326(2):563-76. doi: 10.1124/jpet.108.136630. Epub 2008 May 6. J Pharmacol Exp Ther. 2008. PMID: 18460644 Free PMC article.
-
Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist.Pharmacol Biochem Behav. 2012 Jul;102(1):157-62. doi: 10.1016/j.pbb.2012.03.026. Epub 2012 Apr 4. Pharmacol Biochem Behav. 2012. PMID: 22503967 Free PMC article.
-
A role for glutamate in subjective response to smoking and its action on inhibitory control.Psychopharmacology (Berl). 2011 Jul;216(1):29-42. doi: 10.1007/s00213-011-2189-4. Epub 2011 Feb 9. Psychopharmacology (Berl). 2011. PMID: 21301814 Free PMC article. Clinical Trial.
-
Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats.Psychopharmacology (Berl). 2009 Sep;205(4):655-65. doi: 10.1007/s00213-009-1572-x. Epub 2009 Jun 4. Psychopharmacology (Berl). 2009. PMID: 19495728
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources